BIOLASE Technology, Inc. (NASDAQ: BLTI), a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine, today reported operating results for the first quarter ended March 31, 2006. The Company also announced that Robert E. Grant, the Company’s President, CEO and Acting Chairman of the Board, resigned from those positions effective today to accept a position in the medical aesthetics industry. The Company also announced today the appointment of Jeffrey W. Jones as the Company’s President and Chief Executive Officer and George V. d’Arbeloff as the Company’s Chairman of the Board.
